VALE vs. ASND

Last updated Jun 13, 2026

VALE (Vale S.A.) and ASND (Ascendis Pharma A/S) are both stocks. VALE operates in Other Industrial Metals & Mining (Basic Materials), while ASND operates in Biotechnology (Healthcare). Over the past 10 years, VALE returned 22.05%/yr vs 33.14%/yr for ASND. At a 0.12 correlation, their price movements are largely independent.

Performance

VALE vs. ASND - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vale S.A. (VALE) and Ascendis Pharma A/S (ASND). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VALE achieves a 20.57% return, which is significantly higher than ASND's 2.26% return. Over the past 10 years, VALE has underperformed ASND with an annualized return of 22.05%, while ASND has yielded a comparatively higher 33.14% annualized return.

VALE

• 1D: 2.28%
• 1M: -6.71%
• YTD: 20.57%
• 6M: 23.80%
• 1Y: 73.31%
• 3Y*: 12.85%
• 5Y*: 2.38%
• 10Y*: 22.05%

ASND

• 1D: 1.14%
• 1M: -10.48%
• YTD: 2.26%
• 6M: -1.07%
• 1Y: 27.58%
• 3Y*: 32.88%
• 5Y*: 10.86%
• 10Y*: 33.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

VALE vs. ASND - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VALE Vale S.A.	20.57%	60.70%	-38.83%	1.57%	32.54%	-1.45%	32.40%	2.72%	12.25%	68.03%
ASND Ascendis Pharma A/S	2.26%	54.89%	9.31%	3.13%	-9.22%	-19.34%	19.88%	122.06%	56.39%	97.92%

Correlation

The correlation between VALE and ASND is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Jan 28, 2015	0.12

Fundamentals

Market Cap VALE : $67.15B ASND : $14.07B
EPS VALE : $0.65 ASND : €8.08
PE Ratio VALE : 24.04 ASND : 23.32
PS Ratio VALE : 1.70 ASND : 13.62
PB Ratio VALE : 1.83 ASND : 24.89
Total Revenue (TTM) VALE : $39.53B ASND : €867.51M
Gross Profit (TTM) VALE : $13.65B ASND : €764.89M
EBITDA (TTM) VALE : $14.33B ASND : -€6.94M

Return for Risk

VALE vs. ASND — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VALE

VALE Risk / Return Rank: 89
VALE Sharpe Ratio Rank: 92
VALE Sortino Ratio Rank: 88
VALE Omega Ratio Rank: 88
VALE Calmar Ratio Rank: 88
VALE Martin Ratio Rank: 91

ASND

ASND Risk / Return Rank: 68
ASND Sharpe Ratio Rank: 67
ASND Sortino Ratio Rank: 63
ASND Omega Ratio Rank: 60
ASND Calmar Ratio Rank: 72
ASND Martin Ratio Rank: 76

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VALE vs. ASND - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vale S.A. (VALE) and Ascendis Pharma A/S (ASND). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VALE	ASND	Difference
Sharpe ratio: Return per unit of total volatility	2.30	0.75	+1.55
Sortino ratio: Return per unit of downside risk	2.85	1.28	+1.57
Omega ratio: Gain probability vs. loss probability	1.37	1.15	+0.22
Calmar ratio: Return relative to maximum drawdown	3.71	1.59	+2.12
Martin ratio: Return relative to average drawdown	12.21	4.87	+7.34

VALE vs. ASND - Sharpe Ratio Comparison

The current VALE Sharpe Ratio is 2.30, which is higher than the ASND Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of VALE and ASND, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VALE vs. ASND - Drawdown Comparison

The maximum VALE drawdown since its inception was -92.78%, which is greater than ASND's maximum drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for VALE and ASND.

Drawdown Indicators

	VALE	ASND	Difference
Max Drawdown Largest peak-to-trough decline	-92.78%	-61.72%	-31.06%
Max Drawdown (1Y) Largest decline over 1 year	-19.85%	-17.62%	-2.23%
Max Drawdown (3Y) Largest decline over 3 years	-41.94%	-29.15%	-12.79%
Max Drawdown (5Y) Largest decline over 5 years	-49.79%	-60.46%	+10.67%
Max Drawdown (10Y) Largest decline over 10 years	-57.60%	-61.72%	+4.12%
Current Drawdown Current decline from peak	-11.84%	-12.72%	+0.88%
Average Drawdown Average peak-to-trough decline	-36.69%	-18.90%	-17.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.02%	5.72%	+0.30%

Volatility

VALE vs. ASND - Volatility Comparison

The current volatility for Vale S.A. (VALE) is 9.16%, while Ascendis Pharma A/S (ASND) has a volatility of 13.12%. This indicates that VALE experiences smaller price fluctuations and is considered to be less risky than ASND based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VALE	ASND	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.16%	13.12%	-3.96%
Volatility (6M) Calculated over the trailing 6-month period	26.35%	29.45%	-3.10%
Volatility (1Y) Calculated over the trailing 1-year period	32.06%	37.26%	-5.20%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.47%	48.65%	-13.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	40.84%	51.09%	-10.25%

Dividends

VALE vs. ASND - Dividend Comparison

VALE's dividend yield for the trailing twelve months is around 3.66%, while ASND has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ASND Ascendis Pharma A/S	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
VALE Vale S.A.	3.66%	7.29%	11.41%	7.75%	8.63%	19.70%	2.72%	2.63%	4.16%	3.77%	1.06%	7.48%

Financials

Frequently Asked Questions

Can I hold both VALE and ASND in my portfolio?

VALE and ASND have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VALE or ASND?

ASND has higher volatility (13.12%) compared to VALE (9.16%). In terms of maximum drawdown, VALE dropped -92.78% vs ASND's -61.72%.

Which has better risk-adjusted returns?

VALE currently has the higher Sharpe Ratio (2.30 vs 0.75), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.